Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.4957
+0.1285 (34.99%)
At close: Nov 2, 2026, 4:00 PM EST
0.4600
-0.0357 (-7.20%)
Pre-market: Nov 3, 2026, 7:46 AM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $93.14 million as of November 2, 2026. It is the 25,492nd most valuable company in the world and the 4,143rd biggest in the United States. Its market cap has decreased by 80.96% in one year.
Market Cap
93.14M
Enterprise Value
29.56M
1-Year Change
-80.96%
Global Rank
Country Rank
#4,143 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $93.14M, a decrease of -96.39%. That is a compound annual growth rate of -65.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 93.14M | -69.38% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 90.68M |
| Genelux | 90.52M |
| Tonix Pharmaceuticals Holding | 87.98M |
| NeurAxis | 86.52M |
| Polaryx Therapeutics | 86.27M |
| Rallybio | 85.86M |
| Atara Biotherapeutics | 83.71M |
| Tenaya Therapeutics | 83.17M |